Master Cleanse Secrets - Master Key Discovering new treatments

                                                           
                                 "Master Key" Discovering new treatments for autoimmune diseases Unlock

Imagine a single drug that cover most, if not all, autoimmune diseases such as asthma, inflammatory bowel disease and lupus. This may not be that hard to do, thanks to a team of researchers, a molecule normally used by the body, preventing unnecessary immune reactions discovered. This molecule, pronounced "alpha v beta 6," normally keeps the immune system overreacting when food passes through our bodies, and it could be the key that opens whole new range of therapies for autoimmune diseases . This discovery was made recently in the search report is published in the Journal of Leukocyte Biology published.

"Currently we have no specific methods for treating diseases more radically autoimmune, and all we can do is to temporarily inhibit the clinical symptoms of these diseases," said Chang Ping-yang , a researcher on the work of the Institute of Pathology and Molecular Medicine at McMaster University participated in Ontario, Canada.  Master Cleanse Secrets Info  "Our results have the potential to damage the immune system tolerant to repair so cause the body's immune system to" fix "the current pathologies of its own."

Scientists made the discovery in mice, when she noticed that her bowel alphavbeta6 separated, if have with food intake. Alphavbeta6, taken together with food, the body's immune system induced tolerant cells that produce, ensure that food does not cause an excessive immune response.Master Cleanse Secrets Program  The researchers then alphavbeta6 generated using cultured intestinal cells and found that both could be used to determine the immune cells tolerant to reduce or eliminate out of control to generate immune responses.

"The development of new therapies and cures for diseases is generally a lengthy process that has taken a series of small steps throughout the laboratory to the bedside," said John Wherry, Ph.D., Editor Deputy of the Journal of Leukocyte Biology. "There are times, however, scientists are big jumps instead of forward. Although considerable work remains to determine whether this discovery translate directly into new therapies, reported the discovery of these scientists is exciting alphavbeta6 if it is not surprising. "